Antimicrobial Susceptibility Survey of Invasive Neisseria meningitidis, United States 2012–2016
Abstract Background Historically, antimicrobial resistance has been rare in US invasive meningococcal disease cases. Methods Meningococcal isolates (n = 695) were collected through population-based surveillance, 2012–2016, and national surveillance, 2015–2016. Antimicrobial susceptibility was assess...
Saved in:
Published in | The Journal of infectious diseases Vol. 225; no. 11; pp. 1871 - 1875 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
US
Oxford University Press
01.06.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Abstract
Background
Historically, antimicrobial resistance has been rare in US invasive meningococcal disease cases.
Methods
Meningococcal isolates (n = 695) were collected through population-based surveillance, 2012–2016, and national surveillance, 2015–2016. Antimicrobial susceptibility was assessed by broth microdilution. Resistance mechanisms were characterized using whole-genome sequencing.
Results
All isolates were susceptible to 6 antibiotics (cefotaxime, ceftriaxone, meropenem, rifampin, minocycline, and azithromycin). Approximately 25% were penicillin or ampicillin intermediate; among these, 79% contained mosaic penA gene mutations. Less than 1% of isolates were penicillin, ampicillin, ciprofloxacin, or levofloxacin resistant.
Conclusions
Penicillin- and ampicillin-intermediate isolates were common, but resistance to clinically relevant antibiotics remained rare.
Antimicrobial susceptibility testing of 695 US meningococcal isolates, collected 2012–2016, demonstrated that penicillin- and ampicillin-intermediate isolates were common; resistance to clinically relevant antibiotics remained rare. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 0022-1899 1537-6613 1537-6613 |
DOI: | 10.1093/infdis/jiac046 |